Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
about
Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug developmentA 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatmentMulticellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensionsComprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC.3D tumor models: history, advances and future perspectives.Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.Evaluation of assays for drug efficacy in a three-dimensional model of the lung.Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.Synthesis and evaluation of some new aza-B-homocholestane derivatives as anticancer agents.Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture modelIn-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA
P2860
Q21132280-6E27ACDE-D35F-48C8-9E2C-443EF3E2DDF5Q28641649-7A40FA6E-E072-425A-80FA-2FAC20C17538Q33637214-C41281A0-7ED8-43E8-89B2-A2088FDDE4F6Q35861891-3A091FA2-8074-4E90-80E8-549B0AC1DD50Q36471467-25267991-E4CD-4DCA-88C0-76710F08C71FQ38221694-0CA4D960-9792-411E-AEE4-53FE9AFB0BCBQ38495033-69E0CB27-1ABF-4FC4-AB11-45AA947EBBB5Q38692541-719000C6-77E9-4997-8BC8-263D9BE3A351Q38757759-54CCAEAE-12B6-4978-8450-685A19B98EA4Q38767149-EE65D654-2178-4099-A1DA-02DDD6579F19Q39011568-243BA6CA-4E1E-4E8C-A7C0-FAA55A40A1FDQ47131461-600A8465-30E7-4EB4-A25C-915CB9A0CAE4Q47164952-995B7957-CF93-4B82-B4F7-FD950B7BD119Q47848866-EF427C51-DF4D-48B5-A76C-7AD2BEBAC57BQ57292420-42302C91-4F64-4AA4-AFC1-35956F78B0CEQ58562849-C0AD10A8-0245-4807-A0B4-6F19FF22E811
P2860
Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development, validation and pi ...... for anti-cancer drug testing.
@ast
Development, validation and pi ...... for anti-cancer drug testing.
@en
Development, validation and pi ...... for anti-cancer drug testing.
@nl
type
label
Development, validation and pi ...... for anti-cancer drug testing.
@ast
Development, validation and pi ...... for anti-cancer drug testing.
@en
Development, validation and pi ...... for anti-cancer drug testing.
@nl
prefLabel
Development, validation and pi ...... for anti-cancer drug testing.
@ast
Development, validation and pi ...... for anti-cancer drug testing.
@en
Development, validation and pi ...... for anti-cancer drug testing.
@nl
P2093
P1476
Development, validation and pi ...... for anti-cancer drug testing.
@en
P2093
Aimin Zhou
Janine M Naim
Jennifer Williams
P304
P356
10.1016/J.BMC.2012.12.007
P407
P577
2012-12-14T00:00:00Z